PT973790E - Estra-5, 7-dienos com actividade estrogenica - Google Patents

Estra-5, 7-dienos com actividade estrogenica

Info

Publication number
PT973790E
PT973790E PT98915224T PT98915224T PT973790E PT 973790 E PT973790 E PT 973790E PT 98915224 T PT98915224 T PT 98915224T PT 98915224 T PT98915224 T PT 98915224T PT 973790 E PT973790 E PT 973790E
Authority
PT
Portugal
Prior art keywords
estra
dienes
estrogenic activity
estrogenic
activity
Prior art date
Application number
PT98915224T
Other languages
English (en)
Inventor
Leonard Alexander Mcdonald
Michael Z Kagan
Syed Muzafar Shah
Mark Andrew Collins
Fangming Kong
Panolil Raveendranath
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth Corp filed Critical Wyeth Corp
Publication of PT973790E publication Critical patent/PT973790E/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J21/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J21/005—Ketals
    • C07J21/008—Ketals at position 17
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051—Estrane derivatives
    • C07J1/0059—Estrane derivatives substituted in position 17 by a keto group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J17/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, having an oxygen-containing hetero ring not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J17/005—Glycosides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
    • C07J31/006—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring not covered by C07J31/003

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PT98915224T 1997-04-07 1998-04-02 Estra-5, 7-dienos com actividade estrogenica PT973790E (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US83533697A 1997-04-07 1997-04-07
US85057097A 1997-05-02 1997-05-02

Publications (1)

Publication Number Publication Date
PT973790E true PT973790E (pt) 2003-10-31

Family

ID=27125779

Family Applications (1)

Application Number Title Priority Date Filing Date
PT98915224T PT973790E (pt) 1997-04-07 1998-04-02 Estra-5, 7-dienos com actividade estrogenica

Country Status (15)

Country Link
EP (1) EP0973790B1 (pt)
JP (1) JP2001518896A (pt)
KR (1) KR20010006118A (pt)
CN (1) CN1259137A (pt)
AR (1) AR012341A1 (pt)
AT (1) ATE242263T1 (pt)
AU (1) AU738486B2 (pt)
BR (1) BR9809748A (pt)
CA (1) CA2286457A1 (pt)
DE (1) DE69815329T2 (pt)
DK (1) DK0973790T3 (pt)
ES (1) ES2200334T3 (pt)
NZ (1) NZ500217A (pt)
PT (1) PT973790E (pt)
WO (1) WO1998045315A1 (pt)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002338277B2 (en) * 2001-03-16 2007-11-22 Wyeth Estrogen replacement therapy
EP2268655A4 (en) * 2008-03-24 2013-03-13 Signa Chemistry Llc BIRCH REDUCTION OF STEROIDSUBSTRATES ON ALKALIMETAL SILICA GEL MATERIALS
US9512169B2 (en) 2012-07-10 2016-12-06 Bayer Pharma Aktiengesellschaft 3-substituted estra-1,3,5(10),16-tetraene derivatives, methods for the production thereof, pharmaceutical preparations containing same, and use thereof for the production of medicaments
CA2901632C (en) 2013-02-21 2017-11-07 Bayer Pharma Aktiengesellschaft Estra-1,3,5(10),16-tetraene-3-carboxamides for inhibition of 17.beta.-hydroxysteroid dehydrogenase (akr1 c3)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1093360B (de) * 1958-02-17 1960-11-24 Ayerst Mckenna & Harrison Verfahren zur Herstellung von stabilen antioestrogen wirksamen Verbindungen der Oestranreihe
US2930805A (en) * 1959-01-19 1960-03-29 American Home Prod Novel derivatives of estrane
US3340278A (en) * 1965-05-03 1967-09-05 American Home Prod 5(10), 7-estradiene-3, 17-dione and the process for the production thereof
ATE141051T1 (de) * 1992-04-07 1996-08-15 Neurim Pharma 1991 Verwendung von melatonin zur herstellung eines arzneimittels zur behandlung der gutartigen prostatahyperplasie

Also Published As

Publication number Publication date
JP2001518896A (ja) 2001-10-16
WO1998045315A1 (en) 1998-10-15
AU6946298A (en) 1998-10-30
AR012341A1 (es) 2000-10-18
CA2286457A1 (en) 1998-10-15
EP0973790B1 (en) 2003-06-04
DE69815329T2 (de) 2004-04-29
ATE242263T1 (de) 2003-06-15
NZ500217A (en) 2001-11-30
BR9809748A (pt) 2000-06-20
DK0973790T3 (da) 2003-09-22
AU738486B2 (en) 2001-09-20
CN1259137A (zh) 2000-07-05
ES2200334T3 (es) 2004-03-01
KR20010006118A (ko) 2001-01-26
EP0973790A1 (en) 2000-01-26
DE69815329D1 (de) 2003-07-10

Similar Documents

Publication Publication Date Title
DE69723886D1 (de) Dünne,komfortable,interlabiale absorbierende struktur
FI953523L (fi) Fenyyli-3-dimetyyliamino-propaaniyhdisteet, joilla on farmakologista vaikutusta
MX210210B (es) Nuevos catalizadores
ZA200109847B (en) 3α-hydroxy-3B methoxymethyl-21-heterocycle substituted steroids with anesthetic activity.
DE69805643D1 (de) Membrane-elektroden-anordnung
NL1011101A1 (nl) Honingraat paneel.
EP0662776A3 (de) Funkzellen-Erweiterung.
FI981404L (fi) Tuetut fosfinimiini-Cp-katalyytit
ID22228A (id) Turunan-turunan 16-hidroksi-11-(disubstitusifenil)-estra-4,9-diena
DE69833161D1 (de) Funkgerät
FI960529L (fi) Antineurodegeneratiivisesti vaikuttavat 10-aminoalifatyylidibents (b,f)oksepiinit
FR2720813B1 (fr) Support de structure.
DK0973790T3 (da) Estra-5(10),7-diener med østrogen aktivitet
NO990350D0 (no) Katalysatorer
ES1036909Y (es) Pupitre infantil.
FI972885A0 (fi) Anordning foer utfoering av en divisionoperation, saerskilt i en tredimensionell grafik
FI971570A0 (fi) Styrsystem foer foerbraenningsluften i en ackumulerande, vedeldad eldstad
ES1037395Y (es) Tendedero antilluvia.
HK1024923A (en) Estra-5(10), 7-dienes with estrogenic activity
ID19473A (id) 24-homo-26,27-heksafluoro-kolkalsiferol
FI971438A0 (fi) Koppling laemplig foer spaennings- eller spaenningsfri arbete, saerskilt koppling foer ljusbaogs- eller oeverstoemsskydd
FI971391A0 (fi) Koppling laemplig foer spaenningsarbete, saerskilt koppling foer ljusbaogs- eller oeverstoemsskydd
FI3112U1 (fi) Maila, erityisesti pesäpallomaila
ES1029350Y (es) Nueva estructura de asiento.
ES1029784Y (es) Estructura sostenedora.